Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
Therefore, the agency lacks sufficient information to know whether the drug would cause harm when administered to humans. The agency has classified the product as 503A, a vague category for non-mass-produced compounded products
Heo JH, et al
All authors approved the version to be published
Lanzinger S, Laubner K, Warncke K et al (2024) Clinical characteristics, treatment, and treatment switch after molecular-genetic classification in individuals with maturity-onset diabetes of the young: insights from the multicenter real-world DPV registry
US$ 26.58
US$ 20.33
US$ 21.73
US$ 20.19
US$ 25.63
US$ 29.61
US$ 20.71
